Telemedicine Now Available at a Wholesale Price
MD247, the Tampa Florida based provider of a unique 24/7 program, announced on Sunday that it would now be offering opportunities for wholesale purchase of its telemedicine program for large employers in the Greater Tampa Bay area.
Tampa, FL (PRWEB) October 30, 2012
MD247, the Tampa Florida based provider of a unique 24/7 program, announced on Sunday that it would now be offering opportunities for wholesale purchase of its telemedicine program for large employers in the Greater Tampa Bay area. The healthcare program provides all members 24/7 access to a nationwide network of licensed medical professionals for a consultation price far below that of Urgent Care Clinics.
The MD247 services provide telemedicine program members with the opportunity to conveniently remain either in the comfort of their own home, or otherwise engaged at work, while relaying their medical symptoms to a waiting staff of licensed medical professionals. 24/7 telemedicine is a fiscally sound, and culturally popular alternative which can either supplement or replace traditional bureaucracy burdened health insurance coverage. The MD247 telemedcine program is proving to be particularly attractive to families, who may have members that fall outside of typical health insurance policy coverage due to either age or a pre-existing condition.
Largo Florida based MD247.COM (MD247; MD/247; MD 247; M.D.247; MD-247) provides an affordable telemedicine supplement to existing healthcare services. MD247.COM telemedicine program members have unlimited telephone access to a nationwide medical support team, all with just a single phone call to the MD247.COM telemedicine Chat With a Docto r/Talk to a Nurse Hotline. MD247.COM has a virtual platoon of registered nurses; board certified physicians and a support staff available to members for all non-emergency situations. More information about MD247.COM is available online at http://www.md247.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10067226.htmView Comments and Join the Discussion!